문의해 주셔서 감사합니다.
contact.you.lab.product.request.text
(Business Unit Performance Materials, Sales Support Team)
Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia
+62 21 2988 8557
성공! 귀하의 문의가 영업팀에 제출되었습니다.
pim.add.to.wishlist.popup.error
개의 제품을 찾았습니다
| 요청자의 연락처 세부 정보 | |
| Full name | |
| Company | |
| Position | |
| Telephone number | |
| Work email address | |
| Shipping address | |
Thank you. Your request has been sent.
Urapidil Base is a white crystalline powder. When dissolved, it forms a clear, colorless solution that is free of particles.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Refarmed Chemicals presents Ciprofibrate, a crucial pharmaceutical material developed for clinical efficacy in managing lipid disorders. Developed with the utmost precision, Ciprofibrate is a fibrate-class drug specially formulated as a therapeutic agent to regulate high levels of cholesterol and triglycerides, factors leading to cardiovascular diseases. Our product is synthesized with rigorous compliance to quality standards, evidenced by its Good Manufacturing Practice (GMP) certification. The drug appears as a white or slightly yellow-white crystalline powder, indicative of its purity. Highly soluble in anhydrous ethanol and toluene yet practically insoluble in water, Ciprofibrate facilitates flexibility in pharmaceutical formulation, allowing for both tablet and capsule dosage forms in strengths of 100mg and 200mg. Targeting primary hypercholesterolemia (type IIa or IIb), mixed dyslipidemia, and as preventive treatment against cardiovascular events in high cholesterol patients, Ciprofibrate's composition facilitates the acceleration of cholesterol and triglyceride breakdown and removal from the body. Recommended for bi-daily intake alongside meals, the treatment's efficacy is augmented by adherence to healthy lifestyle choices, including a balanced diet and regular exercise. Safety parameters dictate careful administration especially to those with a history of gallbladder disease, and periodic liver function evaluations are advised. Contraindications include severe renal or hepatic conditions, pregnancy, breastfeeding, or known hypersensitivity to fibrates. Consultation with healthcare professionals is critical when concomitant medications are involved, particularly statins, anticoagulants, and antibiotics. Storage requirements for Ciprofibrate are straightforward — room temperature conditions away from light and moisture ensure stability. As a product from the storied catalogue of Refarmed Chemicals, now part of the DKSH Group, Ciprofibrate is accompanied by dependable documentation for Detailed and Master Files, affirming its reputable standard in pharmaceutical resources.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Refarmed Chemicals, as a distinguished member of the pharmaceutical industry, introduces Finasteride—a vital medication primarily utilized for the treatment of male pattern hair loss, also known as androgenetic alopecia. This condition is common in adult men and involves a receding hairline coupled with thinning of the hair on the crown and temple, often resulting in baldness. Finasteride works effectively by inhibiting the action of dihydrotestosterone (DHT), a hormone with a significant role in promoting hair loss. Finasteride is presented as an oral tablet, with dosing options of either 1mg or 5mg. It is designed to be consumed once daily, and its effectiveness is optimal when taken consistently over time. Adherence to the prescribed dosage is crucial, as is awareness of its strictly adult male usage parameters, as outlined by its contraindications. Produced in full compliance with Good Manufacturing Practice (GMP) standards and verified through various analytical quality control measures, the medication is a white or almost white, crystalline powder. It displays excellent solubility across ethanol, methanol, and methylene chloride, ensuring efficient absorption when ingested. The substance maintains a high purity, with the assay indicating a 98.0% - 102.0% content of the active ingredient, Finasteride, and has tight controls on impurities to ensure patient safety. Further considering safety, it is pivotal to acknowledge the contraindications and side effects Finasteride might present, such as decreased libido and erectile dysfunction. It's also necessary to take precautionary measures regarding potential interactions with other medications and its inappropriate use in women or children, as well as during pregnancy and breastfeeding. For optimal results and patient safety, tablets should be stored in controlled room temperatures, shielded from light and moisture. Our commitment to quality transcends the meticulously crafted tablets to encompass our service and reliability. We extend a partnership towards delivering growth in healthcare, ensuring that our prospective customers receive a product that balances robust efficacy with comprehensive safety measures.
Products still subject to third-party patent protection might be available solely for R&D purposes.